The relative contributions of ecstasy and cannabis to cognitive impairment

Psychopharmacology

Volumn 153, Issue 3, 2001, Pages 373-379

  Croft, R J ^a   Mackay, A J ^a   Mills, A T D ^a   Gruzelier, J G H ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Cannabis; Cognitive impairment; Ecstasy; MDMA; 9 THC

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CANNABIS;

ADULT; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG ABUSE; DRUG USE; FEMALE; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROPSYCHOLOGICAL TEST; NEUROTOXICITY; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; SEROTONINERGIC SYSTEM; SPEECH ARTICULATION; TASK PERFORMANCE;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; COGNITION; COGNITION DISORDERS; FEMALE; HALLUCINOGENS; HUMANS; MALE; MEMORY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROPSYCHOLOGICAL TESTS; TETRAHYDROCANNABINOL;

EID: 0035141263     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130000591     Document Type: Article

References (46)

1. The role of dopaminergic systems in the perinatal sensitivity to 3,4-methylenedioxymethamphetamine-induced neurotoxicity in rats
2. Effects of the endogenous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices
3. Effect of delta9-tetrahydrocannabinol on the synthesis of dopamine and norepinephrine in mouse brain synaptosomes
4. Memory impairment in abstinent MDMA ("ecstasy") users
5. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain
6. Level of use of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in humans correlates with EEG power and coherence
7. Drug abuse in schizophrenic patients: Clinical correlates and reasons for use
8. Cognitive correlates of long-term cannabis use in Costa Rican men
9. Altered serotonin innervation patterns in the forebrain of monkeys treated with (±)3,4-methylenedioxymethamphetamine seven years previously: Factors influencing abnormal recovery
10. Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners
11. Ecstasy (MDMA) dependence
12. Clinical neuropsychology
13. Toxic effect of MDMA on brain serotonin neurons
14. Acute psychological effects of (±)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") are attenuated by the serotonin uptake inhibitor citalopram
15. 5-HT1B receptor knock-out mice exhibit increased exploratory activity and enhanced spatial memory performance in the Morris water maze
16. Modulation by fluoxetine of striatal dopamine release following Delta9-tetrahydrocannabinol: A microdialysis study in conscious rats
17. Serotonin neurotoxicity after (±)3,4-methylenedioxymethamphetamine (MDMA; "ecstasy"): A controlled study in humans
18. Positron emission tomographic evidence of toxic effect of MDMA ("ecstasy") on brain serotonin neurons in human beings
19. Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: A controlled study
20. Cannabis: Effects on memory and the cholinergic limbic system
21. (±)3,4-methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats
22. Recreational use of ecstasy (MDMA) is associated with elevated impulsivity
23. Memory deficits associated with recreational use of "ecstasy" (MDMA)
24. Permissive role of dopamine D(2) receptors in the hypothermia induced by delta(9)-tetrahydrocannabinol in rats
25. The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy')
26. Cognitive performance in recreational users of MDMA of 'ecstasy': Evidence for memory deficits
27. Deficits on conditional associative-learning tasks after frontal- and temporal-lobe lesions in man
28. (±)3,4-methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates
29. 3,4-methylenedioxymethamphetamine, serotonin and memory
30. Neurotoxicology of cannabis and THC: A review of chronic exposure studies in animals
31. In vivo detection of short- and long-term MDMA neurotoxicity - A positron emission tomography study in the living baboon brain
32. Short-term memory impairments in cannabis-dependent adolescents
33. Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate
34. An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine
35. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain
36. Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine
37. Studies of interference in serial verbal reactions
38. Calexcitin transformation of GABAergic synapses: From excitation filter to amplifier
39. Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol
40. Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans
41. Working memory deficits in current and previous users of MDMA ('ecstasy')